Search for Clinical Trial Results
Bile Duct Cancer - 122 Studies Found
Status | Study |
Terminated |
Study Name: Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers Condition:
|
Completed |
Study Name: Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer Condition:
Interventions: |
Completed |
Study Name: Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer Condition:
Interventions: |
Completed |
Study Name: DX-8951f in Treating Patients With Biliary Cancer Condition:
Interventions: Drug: exatecan mesylate |
Terminated |
Study Name: Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Biliary Cancer Condition:
Interventions: |
Completed |
Study Name: Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer Condition:
Interventions: |
Completed |
Study Name: Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer Condition:
Interventions: Drug: dolastatin 10 |
Completed |
Study Name: Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer Condition:
Interventions: |
Terminated |
Study Name: Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer Condition:
Interventions: Drug: becatecarin Cohorts of 3-6 patients receive escalating doses of rebeccamycin analogue until the ma |
Completed |
Study Name: Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer Condition:
Interventions: |